183 related articles for article (PubMed ID: 2879917)
21. Pharmacological and biochemical evidence for metabolism of peptide leukotrienes by guinea-pig airway smooth muscle in vitro.
Snyder DW; Aharony D; Dobson P; Tsai BS; Krell RD
J Pharmacol Exp Ther; 1984 Nov; 231(2):224-9. PubMed ID: 6149304
[TBL] [Abstract][Full Text] [Related]
22. Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison on leukotriene-, methacholine-, histamine- and antigen-induced contractions.
Muccitelli RM; Tucker SS; Hay DW; Torphy TJ; Wasserman MA
J Pharmacol Exp Ther; 1987 Nov; 243(2):467-73. PubMed ID: 2824746
[TBL] [Abstract][Full Text] [Related]
23. Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors.
Lee TH; Austen KF; Corey EJ; Drazen JM
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4922-5. PubMed ID: 6087352
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antiallergic activity of a novel series of 5-lipoxygenase inhibitors.
Kees KL; Musser JH; Chang J; Skowronek M; Lewis AJ
J Med Chem; 1986 Nov; 29(11):2329-34. PubMed ID: 2878078
[TBL] [Abstract][Full Text] [Related]
25. In vivo pharmacologic profile of ONO-1078: a potent, selective and orally active peptide leukotriene (LT) antagonist.
Nakagawa N; Obata T; Kobayashi T; Okada Y; Nambu F; Terawaki T; Aishita H
Jpn J Pharmacol; 1992 Nov; 60(3):217-25. PubMed ID: 1337128
[TBL] [Abstract][Full Text] [Related]
26. The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist.
Krell RD; Aharony D; Buckner CK; Keith RA; Kusner EJ; Snyder DW; Bernstein PR; Matassa VG; Yee YK; Brown FJ
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):978-87. PubMed ID: 2158259
[TBL] [Abstract][Full Text] [Related]
27. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
[TBL] [Abstract][Full Text] [Related]
28. Biological activities of a chemically synthesized form of leukotriene E4.
Welton AF; Crowley HJ; Miller DA; Yaremko B
Prostaglandins; 1981 Feb; 21(2):287-96. PubMed ID: 6261299
[TBL] [Abstract][Full Text] [Related]
29. The pharmacological evaluation of LY 170680, a novel leukotriene D4 and E4 antagonist in the guinea-pig.
Boot JR; Bond A; Gooderham R; O'Brien A; Parsons M; Thomas KH
Br J Pharmacol; 1989 Sep; 98(1):259-67. PubMed ID: 2553189
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activity of new leukotriene antagonists (racemates and enantiomerically pure compounds).
Anagnostopulos C; Bartmann W; Beck G; Below P; Bergmann A; Linz W; Schacht U; Schölkens BA; Wess G
Biomed Biochim Acta; 1988; 47(10-11):S190-3. PubMed ID: 3248106
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological evidence for a distinct leukotriene C4 receptor in guinea-pig trachea.
Snyder DW; Krell RD
J Pharmacol Exp Ther; 1984 Dec; 231(3):616-22. PubMed ID: 6094796
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and pharmacological investigation of some novel 2-methyl-3-(substituted methylamino)-(3H)-quinazolin-4-ones as histamine H1-receptor blockers.
Alagarsamy V
Pharmazie; 2004 Oct; 59(10):753-5. PubMed ID: 15544052
[TBL] [Abstract][Full Text] [Related]
33. A novel leukotriene D4/E4 antagonist, SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid).
Ahnfelt-Rønne I; Kirstein D; Kaergaard-Nielsen C
Eur J Pharmacol; 1988 Oct; 155(1-2):117-28. PubMed ID: 2854067
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiallergy activity of 10-oxo-10H-pyrido[1,2-a]thieno[3,2-d]pyrimidines and 10-oxo-10H-pyrido[1,2-a]thieno[3,4-d]pyrimidines.
Connor DT; Sorenson RJ; Cetenko WA; Kerbleski JJ; Tinney FJ
J Med Chem; 1984 Apr; 27(4):528-30. PubMed ID: 6142956
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and pharmacological characterization of ICI 198,615: a peptide leukotriene receptor antagonist.
Krell RD; Kusner EJ; Aharony D; Giles RE
Eur J Pharmacol; 1989 Jan; 159(1):73-81. PubMed ID: 2565238
[TBL] [Abstract][Full Text] [Related]
36. New potent antagonists of leukotrienes C4 and D4. 1. Synthesis and structure-activity relationships.
Nakai H; Konno M; Kosuge S; Sakuyama S; Toda M; Arai Y; Obata T; Katsube N; Miyamoto T; Okegawa T
J Med Chem; 1988 Jan; 31(1):84-91. PubMed ID: 3336036
[TBL] [Abstract][Full Text] [Related]
37. Pyrido[2,1-b]quinazolinecarboxylic acids as orally active antiallergy agents.
Tilley JW; LeMahieu RA; Carson M; Kierstead RW; Baruth HW; Yaremko B
J Med Chem; 1980 Jan; 23(1):92-5. PubMed ID: 7359521
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and pharmacological characterization of a series of leukotriene analogues with antagonist and agonist activities.
Bernstein PR; Vacek EP; Adams EJ; Snyder DW; Krell RD
J Med Chem; 1988 Mar; 31(3):692-6. PubMed ID: 2831366
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and LTD4-antagonist activity of desamino-2-nor-leukotriene analogs.
Perchonock CD; Uzinskas I; Ku TW; McCarthy ME; Bondinell WE; Volpe BW; Gleason JG; Weichman BM; Muccitelli RM; DeVan JF
Prostaglandins; 1985 Jan; 29(1):75-81. PubMed ID: 3975429
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.
Hay DW; Muccitelli RM; Tucker SS; Vickery-Clark LM; Wilson KA; Gleason JG; Hall RF; Wasserman MA; Torphy TJ
J Pharmacol Exp Ther; 1987 Nov; 243(2):474-81. PubMed ID: 2824747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
